Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Avaxim
Active Ingredient: Hepatitis A virus formaldehyde inactivated, GBM strain 160U
Dosage Form: Suspension for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Sanofi Pasteur SA, Marcy L’Etoile, France
Product: Vivaxim
Active Ingredients: Capsular polysaccharide typhoid vaccine 25µg
Hepatitis A virus formaldehyde inactivated, GBM strain 160U
Dosage Form: Solution for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Sanofi Pasteur SA, Val-De-Reuil Cedex, France
Dated this 13th day of November 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).